Genmab A/S (CPH:GMAB)
1,399.50
+12.50 (0.90%)
Aug 4, 2025, 12:59 PM CET
Genmab Employees
Genmab had 2,682 employees as of December 31, 2024. The number of employees increased by 478 or 21.69% compared to the previous year.
Employees
2,682
Change (1Y)
478
Growth (1Y)
21.69%
Revenue / Employee
$8,452,973
Profits / Employee
$2,981,306
Market Cap
85.30B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2,682 | 478 | 21.69% |
Dec 31, 2023 | 2,204 | 544 | 32.77% |
Dec 31, 2022 | 1,660 | 448 | 36.96% |
Dec 31, 2021 | 1,212 | 431 | 55.19% |
Dec 31, 2020 | 781 | 233 | 42.52% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Novo Nordisk | 77,349 |
Coloplast | 16,639 |
Demant | 22,639 |
ALK-Abelló | 2,753 |
H. Lundbeck | 5,707 |
Ambu A/S | 5,196 |
Zealand Pharma | 335 |
Bavarian Nordic | 1,605 |
Genmab News
- 19 days ago - Genmab reports Q2 Darzalex net sales of $3.54 billion - Seeking Alpha
- 19 days ago - Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2025 - GlobeNewsWire
- 4 weeks ago - Genmab Announces Changes to its Executive Committee - GlobeNewsWire
- 4 weeks ago - Completion of Share Buy-back Program - GlobeNewsWire
- 5 weeks ago - Genmab: This Is Anything But A Value Trap, Yet It Is Currently Priced As One - Seeking Alpha
- 5 weeks ago - Transactions in Connection with Share Buy-back Program - GlobeNewsWire
- 6 weeks ago - Capital Increase in Genmab as a Result of Employee Warrant Exercise - GlobeNewsWire
- 6 weeks ago - Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons - GlobeNewsWire